发明授权
US07544500B2 Process for the production of a reversibly inactive acidified plasmin composition
无效
用于生产可逆失活的酸化纤溶酶组合物的方法
- 专利标题: Process for the production of a reversibly inactive acidified plasmin composition
- 专利标题(中): 用于生产可逆失活的酸化纤溶酶组合物的方法
-
申请号: US10692105申请日: 2003-10-23
-
公开(公告)号: US07544500B2公开(公告)日: 2009-06-09
- 发明人: Rita T. Bradley , Scott A. Cook , Christopher A. Dadd , Jonathan D. Kent , Marina N. Korneyeva , Valery V. Novokhatny , James F. Rebbeor , Christopher J. Stenland , Jonathan S. Strauss , Jarrett C. Terry , Jeffrey A. Yuziuk
- 申请人: Rita T. Bradley , Scott A. Cook , Christopher A. Dadd , Jonathan D. Kent , Marina N. Korneyeva , Valery V. Novokhatny , James F. Rebbeor , Christopher J. Stenland , Jonathan S. Strauss , Jarrett C. Terry , Jeffrey A. Yuziuk
- 申请人地址: US NC Research Triangle Park
- 专利权人: Talecris Biotherapeutics, Inc.
- 当前专利权人: Talecris Biotherapeutics, Inc.
- 当前专利权人地址: US NC Research Triangle Park
- 代理机构: Womble Carlyle Sandridge & Rice PLLC
- 主分类号: C12N9/50
- IPC分类号: C12N9/50 ; C12N9/68 ; C12N9/70
摘要:
Disclosed is both a process for producing a reversibly inactive acidified plasmin by activating plasminogen and a process for producing a purified plasminogen. The produced plasmin is isolated and stored with a low pH-buffering capacity agent to provide a substantially stable formulation. The purified plasminogen is typically purified from a fraction obtained in the separation of immunoglobulin from Fraction II+III chromatographic process and eluted at a low pH. The reversibly inactive acidified plasmin may be used in the administration of a thrombolytic therapy.
公开/授权文献
信息查询